Market Movers Today: PepsiCo Earnings Miss, SK Hynix ADR Surge, AstraZeneca Trial Fails, and Oil Retreats
The post Market Movers Today: PepsiCo Earnings Miss, SK Hynix ADR Surge, AstraZeneca Trial Fails, and Oil Retreats appeared on BitcoinEthereumNews.com. Quick Summary PepsiCo exceeded revenue forecasts but stock declined due to sluggish North American snack performance and conservative forward guidance SK Hynix’s American Depositary Receipt offering received overwhelming demand, fueled by aggressive AI investor interest AstraZeneca stock tumbled following the failure of its experimental cardiovascular drug in late-stage clinical testing U.S. equity markets advanced amid geopolitical uncertainty, with AI-focused and mega-cap technology stocks leading gains Crude oil prices retreated, providing relief on inflation pressures and boosting airline and consumer-facing sectors PepsiCo Surpasses Revenue Targets Yet Stock Slides PepsiCo delivered quarterly revenue figures that topped analyst expectations, supported by robust international performance and effective pricing strategies across its p